Synaptive Medical Receives FDA 510(k) Clearance for Near-Infrared...

Near-Infrared fluorescence now available on Modus X robotic exoscope, complementing system’s existing advanced fluorescence capabilities...

Synaptive Medical Welcomes Chris Marrus as New Chief...

Synaptive Medical Inc., a global med tech and technology company solving surgical, imaging and data...

New cohort study shows use of Synaptive’s robotic...

A new cohort study published in World Neurosurgery by the Neurosurgery Department at Medical University...

Synaptive Medical Introduces Cutting-Edge Modus X Robotic Exoscope...

Synaptive Medical Introduces Cutting-Edge Modus X Robotic Exoscope in Europe with Its First Installation at...

Synaptive Medical Announces Timothy J. Scannell as New...

Former President and Chief Operating Officer of Stryker takes on position as Chair of Synaptive...

Synaptive Medical Welcomes Provincial Investment to Expand Manufacturing...

Toronto, Canada [August 2, 2023] – Synaptive Medical has received $900,000 in support from the...

Synaptive Announces U.S. and Canadian Availability of Next-Generation...

Toronto, Canada (March 22, 2023) - Synaptive Medical Inc., a global medical technology innovator, announced...

Synaptive Announces a $40 Million Investment from Export...

Synaptive Announces a $40 Million Investment from Export Development Canada (EDC) to Accelerate Surgical, Imaging...